Seema Singhal
Professor · Feinberg School of Medicine
Credentials: · · ·
History
Research
A phase 2 study of bortezomib in relapsed, refractory myeloma
New England Journal of Medicine · 2003 · 2,206 citations
Antitumor activity of thalidomide in refractory multiple myeloma
New England Journal of Medicine · 1999 · First of 12 authors · 2,120 citations
The Lancet · 2016 · 711 citations
175 papers
- BB
24 papers
24 papers
21 papers
21 papers
- NR
21 papers · 5 as a fellow
21 papers
- MT
19 papers
Clinical trials
- 2006–2009
Principal investigator · Completed · Phase 1
Facet Biotech